{"id":151582,"name":"INDIVIOR, INC.","slug":"indivior-inc","state":"VA","description":"Healthcare company","totalSpending":1550000,"filings":27,"yearlySpending":[{"year":2018,"income":270000},{"year":2019,"income":160000},{"year":2020,"income":240000},{"year":2021,"income":240000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":160000}],"firms":["WILLIAMS AND JENSEN, PLLC"],"lobbyists":["KARINA LYNCH","CHERYL JAEGER","SUSAN HIRSCHMANN","MELINDA MAXFIELD","MATTHEW HOEKSTRA","GEORGE OLSEN","CHRISTOPHER HATCHER","CHRISTOPHER WILCOX","NICOLE BERTSCH","GRANT BARBOSA","JEANNE HAGGERTY","DANIEL ZIEGLER","ALEC ARAMANDA"],"issues":["HCR","TAX","BUD","MMM",null],"sampleDescriptions":["S. 916, Protecting Patient Access to emergency Medications Act of 2017; H.R.5205 Ensuring Patient Access to substance Use Disorder Treatments Act of 2018; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; H.R. 1492 Medical Controlled Substances Transportation Act of 2017; Implementation of the CARA Act; H.R. 1628 American Health Care Act of 2017.","Issues related to tax.","S. 916, Protecting Patient Access to emergency Medications Act of 2017; H.R.5205 Ensuring Patient Access to substance Use Disorder Treatments Act of 2018; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; H.R. 1492 Medical Controlled Substances Transportation Act of 2017; Implementation of the CARA Act.","S. 916, Protecting Patient Access to emergency Medications Act of 2017; H.R.5205 Ensuring Patient Access to substance Use Disorder Treatments Act of 2018; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; H.R. 1492 Medical Controlled Substances Transportation Act of 2017; Implementation of the CARA Act.  H.R. 6, Support for Patients and Communities Act.","Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment; Implementation of CARA Act.  H.R. 6, Support for Patients and Communities Act.","Issues related to tax.  Tax credits and tax issues related to the pharmaceutical industry.","Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment; Implementation of CARA Act.  H.R. 6, Support for Patients and Communities Act.  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.","Issues related to Drug Enforcement Agency (DEC) implementation of S. 916; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; Implementation of CARA Act.   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.","Opioid Addiction Treatment policies.  Appropriation issues related to DEA.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.","Issues related to Drug Enforcement Agency (DEC) implementation of S. 916; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; Implementation of CARA Act.   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  H.R. 4712 Fairness in Orphan Drug Exclusivity Act.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.","Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.","Issues related to Drug Enforcement Agency (DEC) implementation of S. 916; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; Implementation of CARA Act.   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  H.R. 4712 Fairness in Orphan Drug Exclusivity Act.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.  Policies impacting orphan drug approval and reimbursement, including H.R. 4712/S. 3272, Fairness in Orphan Drug Exclusivity Act.","Opioid Addiction Treatment policies.  Appropriation issues related to DEA.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136; and  H.R. 133, Consolidated  Appropriations Act, 2021, Public Law No: 116-260.","Issues related to Drug Enforcement Agency (DEC) implementation of S. 916; Reimbursement issues; issues related to opioid addiction; issues related to NIH/HHS funding levels; issues related to funding for CARA, medication assisted treatment and 21st Century Cures Act; Implementation of CARA Act.   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  H.R. 4712 Fairness in Orphan Drug Exclusivity Act.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.  Policies impacting orphan drug approval and reimbursement, including H.R. 4712/S. 3272, Fairness in Orphan Drug Exclusivity Act; and  H.R. 133, Consolidated  Appropriations Act, 2021, Public Law No: 116-260.","Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136; and  H.R. 133, Consolidated  Appropriations Act, 2021, Public Law No: 116-260.","General education on Issues related to the Drug Enforcement Agency (DEA); issues related to opioid addiction and treatment, including NIH/HHS funding levels; Policies impacting the US efforts to address the Covid 19 pandemic, including the American Rescue Plan Act of 2021.","Policies impacting U.S. efforts to address the Covid-19 pandemic, including the American Rescue Plan Act of 2021, PL 117-2, HR 1319.  Policies related to Medicaid reimbursement and access to treatment.","Policies impacting US efforts to address the Covid 19 pandemic, including the American Rescue Plan At of 2021; PL 117-2, HR 1319.  Issues related to budget reconciliation.","American Rescue Plan and funding for substance use disorder and mental health treatment (PL 117-2), the Medicaid Re-entry Act (H.R. 955/S. 445); policies related to reimbursement of substance use disorder treatment (no specific legislation). Possible changes in reimbursement for pharmaceuticals (H.R. 3 and any successor legislation)","Policies impacting US efforts to address the Covid 19 pandemic, including the American Rescue Plan At of 2021; PL 117-2, HR 1319.  Issues related to budget reconciliation.  H.R. 3684."],"years":[2018,2019,2020,2021,2022,2023,2024]}